Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,656 | 22,388 | 81,339 | -134,376 | -92,225 |
| Depreciation Amortization | 952 | 4,054 | 3,072 | 2,097 | 1,037 |
| Accounts receivable | -74,068 | -101,279 | -80,605 | 50,798 | 29,680 |
| Accounts payable and accrued liabilities | -7,741 | 18,223 | 28 | 15,666 | 16,711 |
| Other Working Capital | -105,747 | -85,118 | -107,665 | 28,743 | 10,404 |
| Other Operating Activity | 106,982 | 187,059 | 163,334 | -11,893 | -19,017 |
| Operating Cash Flow | $-60,966 | $45,327 | $59,503 | $-48,965 | $-53,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -313 | -205 | -57 | -8 |
| Investing Cash Flow | $N/A | $-313 | $-205 | $-57 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 86 | 8,895 | 7,636 | 6,839 | 281 |
| Other Financing Activity | -22 | -11 | -11 | -7 | -7 |
| Financing Cash Flow | $64 | $8,884 | $7,625 | $6,832 | $274 |
| Exchange Rate Effect | -131 | 1,250 | 1,066 | 1,044 | 359 |
| Beginning Cash Position | 467,760 | 412,612 | 412,612 | 412,612 | 412,612 |
| End Cash Position | 406,727 | 467,760 | 480,601 | 371,466 | 359,827 |
| Net Cash Flow | $-61,033 | $55,148 | $67,989 | $-41,146 | $-52,785 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,966 | 45,327 | 59,503 | -48,965 | -53,410 |
| Capital Expenditure | N/A | -313 | -205 | -57 | -8 |
| Free Cash Flow | -60,966 | 45,014 | 59,298 | -49,022 | -53,418 |